Contents of Cancer Biology & Medicine in 2023（Issue 1-3）
As a peer-reviewed open-access journal, Cancer Biology & Medicine (CBM) is published by China Anti-Cancer Association and Tianjin Medical University Cancer Institute & Hospital. It focuses on translational cancer research, dedicating to narrowing the gap between bench and bedside. CBM strictly adheres to guidelines of the International Committee of Medical Journal Editors (ICMJE), and Committee on Publication Ethics (COPE). The journal is now indexed in Science Citation Index Expanded (SCIE, IF=5.347, 5-year IF=6.624) and MEDLINE. All full texts are available in PubMed via http://www.ncbi.nlm.nih.gov/pmc/journals/2000/.
The contents of the 1st-3rd issue are as followed. Welcome to submit your work to CBM, which is a trusty international platform, to disseminate your research and viewpoints.
ISSUE 1
Reviews
Major roles of the circadian clock in cancer
Chen Huang, Chenliang Zhang, Yubin Cao, Jian Li and Feng Bi
Cancer Biology & Medicine January 2023, 20 (1) 1-24;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0474
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, Yiwen Sun, Yannan Bai, Ruhang Zhu, Zhuxin Li, Wenbing Sun and Lemin Zheng
Cancer Biology & Medicine January 2023, 20 (1) 25-43;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0449
Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment
Pengfei Zhu, Hongrui Lu, Mingxing Wang, Ke Chen, Zheling Chen and Liu Yang
Cancer Biology & Medicine January 2023, 20 (1) 44-55;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0491
Original Articles
Acetylated-PPARγ expression is regulated by different P53 genotypes associated with the adipogenic differentiation of polyploid giant cancer cells with daughter cells
Kexin Zhang, Xiaohui Yang, Minying Zheng, Yidi Ning and Shiwu Zhang
Cancer Biology & Medicine January 2023, 20 (1) 56-76;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0432
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study
Huishou Fan, Weida Wang, Ya Zhang, Jianxiang Wang, Tao Cheng, Lugui Qiu, Xin Wang, Zhongjun Xia and Gang An
Cancer Biology & Medicine January 2023, 20 (1) 77-87;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0612
ISSUE 2
Editorial
Optimization of regional nodal irradiation in the era of sentinel lymph node biopsy
Zhao Bi, Xue’er Wang, Pengfei Qiu, Peng Chen and Yongsheng Wang
Cancer Biology & Medicine February 2023, 20 (2) 89-92;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0625
Perspectives
Intercellular transmission of cGAS-STING signaling in cancer
Qirou Wu, Xiaohong Leng and Pinglong Xu
Cancer Biology & Medicine February 2023, 20 (2) 93-97;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0750
Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
Hang Zhang, Fan Yang, Yi Xiao, Yi-Zhou Jiang and Zhi-Ming Shao
Cancer Biology & Medicine February 2023, 20 (2) 98-103;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0767
Review
Circular RNAs: implications of signaling pathways and bioinformatics in human cancer
Fan Hu, Yin Peng, Xinmin Fan, Xiaojing Zhang and Zhe Jin
Cancer Biology & Medicine February 2023, 20 (2) 104-128;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0466
Consensus
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Ping Li, Yang Liu, Yun Liang, Jian Bo, Sujun Gao, Yongxian Hu, Yu Hu, He Huang, Xiaojun Huang, Hongmei Jing, Xiaoyan Ke, Jianyong Li, Yuhua Li, Qifa Liu, Peihua Lu, Heng Mei, Ting Niu, Yongping Song, Yuqin Song, Liping Su, Sanfang Tu, Jianxiang Wang, Depei Wu, Zhao Wang, Kailin Xu, Zhitao Ying, Qingming Yang, Yajing Zhang, Fengxia Shi, Bin Zhang, Huilai Zhang, Xi Zhang, Mingfeng Zhao, Weili Zhao, Xiangyu Zhao, Liang Huang, Jun Zhu, Wenbin Qian, Weidong Han and Aibin Liang
Cancer Biology & Medicine February 2023, 20 (2) 129-146;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0585
Original Articles
Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer
Jiaming Liu, Lu Yao, Jie Sun, Li Hu, Jiuan Chen, Juan Zhang, Ye Xu and Yuntao Xie
Cancer Biology & Medicine February 2023, 20 (2) 147-154;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0593
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
Yimeng Chen, Xue Wang, Feng Du, Jian Yue, Yiran Si, Xiaochen Zhao, Lina Cui, Bei Zhang, Ting Bei, Binghe Xu and Peng Yuan
Cancer Biology & Medicine February 2023, 20 (2) 155-168;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0525
ISSUE 3
Perspectives
Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
Jiali Zhang, Bin Liu, Minchao Lyu and Yourong Duan
Cancer Biology & Medicine March 2023, 20 (3) 169-173;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0745
Extracellular vesicle-mediated heterogeneous communication between cancer and the lymphatic system facilitates lymphatic metastasis
Changhao Chen, Yuming Luo, Hanhao Zheng, Dingwen Zhang, Yao Kong, Jiabin Yang, Mingjie An, Yan Lin, Daowei Lin and Rufu Chen
Cancer Biology & Medicine March 2023, 20 (3) 174-180;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0007
Review
Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
Tiancheng Zhang, Youpei Lin and Qiang Gao
Cancer Biology & Medicine March 2023, 20 (3) 181-195;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0002
Original Articles
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma
Tianxing Zhou, Quan Man, Xueyang Li, Yongjie Xie, Xupeng Hou, Hailong Wang, Jingrui Yan, Xueqing Wei, Weiwei Bai, Ziyun Liu, Jing Liu and Jihui Hao
Cancer Biology & Medicine March 2023, 20 (3) 196-217;
DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0569
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity
Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang and Yingying Xu
Cancer Biology & Medicine March 2023, 20 (3) 218-228;